Zhongwei Zhang Izumi Tanaka Rika Nakahashi-Ouchida Peter B Ernst Hiroshi Kiyono Yosuke Kurashima
Seminars in immunopathology Jan 2024 [Refereed]
Glycoprotein 2 (GP2) is a widely distributed protein in the digestive tract, contributing to mucosal barrier maintenance, immune homeostasis, and antigen-specific immune response, while also being linked to inflammatory bowel disease (IBD) pathoge...
BACKGROUND: Biologics are increasingly being used in patients with severe uncontrolled asthma. However, the trends in their use for treating severe asthma in Japan remain unclear. METHODS: The number of patients with asthma prescribed omalizumab o...
Shingo Umemoto Rika Nakahashi-Ouchida Yoshikazu Yuki Shiho Kurokawa Tomonori Machita Yohei Uchida Hiromi Mori Tomoyuki Yamanoue Takehiko Shibata Shin-Ichi Sawada Kazuya Ishige Takashi Hirano Kohtaro Fujihashi Kazunari Akiyoshi Yosuke Kurashima Daisuke Tokuhara Peter B Ernst Masashi Suzuki Hiroshi Kiyono
NPJ vaccines 8(1) 106-106 Jul 2023 [Refereed]
Respiratory syncytial virus (RSV) is a leading cause of upper and lower respiratory tract infection, especially in children and the elderly. Various vaccines containing the major transmembrane surface proteins of RSV (proteins F and G) have been t...
Trends in molecular medicine 29(2) 124-140 Feb 2023 [Refereed]
Nasal vaccines induce pathogen-specific dual protective immunity at mucosal surfaces and systemically throughout the body. Consequently, nasal vaccines both prevent pathogen invasion and reduce disease severity. Because of these features, nasal va...
○○学科